Patanase and Levoxyl drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Patanase (olopatadine hydrochloride) and Levoxyl (levothyroxine sodium). Common drug interactions include dyspnoea among females and disability among males.

The phase IV clinical study analyzes what interactions people have when they take Patanase and Levoxyl. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Patanase?

Patanase has active ingredients of olopatadine hydrochloride. It is often used in allergies. eHealthMe is studying from 1,514 Patanase users. Check the latest studies of Patanase.

What is Levoxyl?

Levoxyl has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 25,178 Levoxyl users. Check the latest studies of Levoxyl.



On Jul, 18, 2026

15 people who take Patanase and Levoxyl together, and have interactions are studied.

Patanase and Levoxyl drug interactions.

What are the common drug interactions of Patanase and Levoxyl, by gender? *:

female:

  1. Dyspnoea (difficult or laboured respiration)
  2. Fatigue (feeling of tiredness)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Bone density decreased
  6. Chronic kidney disease
  7. Emotional distress
  8. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  9. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  10. Osteopenia (a condition where bone mineral density is lower than normal)

male:

  1. Disability
  2. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  3. Onychoclasis (breaking of the nails)
  4. Pain
  5. Post procedural haemorrhage (post procedural bleeding)
  6. Renal cyst (kidney cyst)
  7. Tremor (trembling or shaking movements in one or more parts of your body)
  8. Neuropathy peripheral (surface nerve damage)
  9. Hypercholesterolaemia (high levels of cholesterol in the blood)
  10. Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously)

What are the common drug interactions of Patanase and Levoxyl, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Acne (skin problems that cause pimples)
  2. Anaemia (lack of blood)
  3. Dyspnoea (difficult or laboured respiration)
  4. Fatigue (feeling of tiredness)
  5. Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)
  6. Nocturia (the need to get up in the night to urinate)
  7. Thrombosis (formation of a blood clot inside a blood vessel)
  8. Vaginal haemorrhage (vaginal bleeding)

50-59:

  1. Chronic kidney disease
  2. Emotional distress
  3. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  4. Fatigue (feeling of tiredness)
  5. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  6. Osteopenia (a condition where bone mineral density is lower than normal)
  7. Osteoporosis postmenopausal (weak bone with possibility to break after stopped menstrual cycles)
  8. Pain
  9. Renal failure (kidney dysfunction)
  10. Renal tubular necrosis (death of kidney tubules)

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Burning sensation
  3. Dry eye (lack of adequate tears)
  4. Local swelling (swelling at the site of some application of substance or injury)
  5. Oedema peripheral (superficial swelling)
  6. Peripheral swelling
  7. Tooth erosion (dissolving teeth)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 53.33%
  2. Allergic Sinusitis: 3 people, 20.00%
  3. Uterine Leiomyoma (uterine benign tumour derived from smooth muscle): 2 people, 13.33%
  4. Stress And Anxiety: 2 people, 13.33%
  5. Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 13.33%
  6. Hypersensitivity: 2 people, 13.33%
  7. Hiv Infection: 2 people, 13.33%
  8. High Blood Pressure: 2 people, 13.33%
  9. Genital Herpes (herpes infection of genital): 2 people, 13.33%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Patanase and Levoxyl?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Patanase and Levoxyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Patanase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Levoxyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Patanase and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levoxyl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on olopatadine hydrochloride and levothyroxine sodium (the active ingredients of Patanase and Levoxyl, respectively), and Patanase and Levoxyl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: